ISRCTN26805203已完成未知
Intensified treatment at the onset of diagnosis of type 2 diabetes mellitus in drug naive patients in the asian population
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 285
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Newly diagnosed patients with type 2 diabetes
- •2. Had not receievd any prior medication for diabetes
- •3. Aged 18 – 80 years
- •4. Asian ethnicity (Pakistani population)
排除标准
- •1. Previous history of ischaemic heart disease
- •2. Previous history of stroke or other cerebrovascular disease
- •3. Previous history of chronic kidney disease
研究者
相似试验
已完成
不适用
Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX)ndifferentiated arthritis, probable rheumatoid arthritis according to ACR-1958 criteriaMusculoskeletal DiseasesOther arthrosisISRCTN21334657eiden University Medical Center (LUMC) (Netherlands)110
招募中
1 期
CAR-T-cell treatment for untreated high risk MANtle Cell LymphomaMantle Cell Lymphoma (MCL)MedDRA version: 21.0Level: PTClassification code: 10026805Term: Mantle cell lymphoma stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026803Term: Mantle cell lymphoma stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026804Term: Mantle cell lymphoma stage III Class: 100000004864CTIS2022-502405-15-01Klinikum Der Universitat Munchen AöR91
尚未招募
不适用
Should a patient with a clinically suspected scaphoid fracture be treated with a cast?clinical suspected scaphoid fracture. Klinische verdenking scaphoid fractuurNL-OMON20183Erasmus MC180
尚未招募
不适用
Intensification of treatment in people with an obsessive compulsive disorder who do not recover sufficiently from regular ERP treatment: a stepped care approachObsessive compulsive disorder10002861NL-OMON56782HSK Groep35
进行中（未招募）
2 期
Phase II study of intensive treatment for newly diagnosed elderly acute myeloid leukemia, fitted for standard chemotherapy like younger adults, by Japan Adult Leukemia Study Group (JALSG-GML219)acute myeloid leukemiaJPRN-jRCTs041190088Ito Yoshikazu128